WithdrawnNot Applicable

Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial

Stopped: Never approved by the IRB

0Started 2016-03

Plain-language summary

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with monographically morbidly adherent placenta with or without a placenta previa. * Scheduled delivery via cesarean hysterectomy Exclusion Criteria: * Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor, severe preeclampsia, other medical/fetal indication for delivery as determined by the managing physician).

What they're measuring

Composite neonatal morbidity

Timeframe: Within 72 hours of newborn discharge

Maternal neonatal morbidity

Timeframe: Within 72 hours of patient discharge

Trial details

NCT IDNCT02635412

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03

View on ClinicalTrials.gov More Morbidly Adherent Placenta trials